Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Feb 6, 2009

29777_dirs_2009-02-05_eaf48be4-9866-478f-bdd4-0baeb61bef2a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-11-12

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-11-12 Common shares without par value G 950 Disposed 98378 Direct
2008-11-17 Common shares without par value G 40 Disposed 98338 Direct
2009-02-03 Common shares without par value M 11816 $54.30 Acquired 110154 Direct
2009-02-03 Common shares without par value M 1867 $53.55 Acquired 112021 Direct
2009-02-03 Common shares without par value S 13683 $56.00 Disposed 98338 Direct
2009-02-03 Common shares without par value M 3065 $32.6111 Acquired 101403 Direct
2009-02-03 Common shares without par value M 3050 $33.2314 Acquired 104453 Direct
2009-02-03 Common shares without par value M 2454 $41.0317 Acquired 106907 Direct
2009-02-03 Common shares without par value F 5432 $55.57 Disposed 101475 Direct
2008-11-12 Common shares without par value G 300 Acquired 1598 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-03 Option (right to buy) $54.30 M 11816 Disposed 2009-02-11 Common Shares (11816) Direct
2009-02-03 Option (right to buy) $53.55 M 1867 Disposed 2009-02-11 Common Shares (1867) Direct
2009-02-03 Option (right to buy) $32.6111 M 3065 Disposed 2010-02-10 Common Shares (3065) Direct
2009-02-03 Option (right to buy) $33.2314 M 3050 Disposed 2013-02-13 Common Shares (3050) Direct
2009-02-03 Option (right to buy) $41.0317 M 2454 Disposed 2014-02-19 Common Shares (2454) Direct
2009-02-03 Option (right to buy) $55.57 A 1798 Acquired 2010-02-10 Common Shares (1798) Direct
2009-02-03 Option (right to buy) $55.57 A 1823 Acquired 2013-02-13 Common Shares (1823) Direct
2009-02-03 Option (right to buy) $55.57 A 1811 Acquired 2014-02-19 Common Shares (1811) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 15884 Indirect
Common shares without par value 30000 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 4, 2009.

F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Includes shares acquired under the Abbott Laboratories Dividend Re-investment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16a-(11).

F4: Reporting person disclaims beneficial ownership of all securities held by his son.

F5: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.